FDA inspection
CKD Bio Corporation: FDA inspection ending Nov 18, 2022
FDA inspection 1195625 · No Action Indicated (NAI) · Ansan
Key facts
| Inspection ID | 1195625 |
|---|---|
| Firm | CKD Bio Corporation |
| FEI number | 3002806679 |
| Address | 292 Sinwon-Ro; Danwon |
| City | Ansan |
| Country | Korea (the Republic of) |
| Fiscal year | 2023 |
| Inspection end date | Nov 18, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data